Ascentage Pharma Group International (AAPG) Long-Term Deferred Tax: 2022-2024

Historic Long-Term Deferred Tax for Ascentage Pharma Group International (AAPG) over the last 3 years, with Dec 2024 value amounting to $7.0 million.

  • Ascentage Pharma Group International's Long-Term Deferred Tax was N/A to $4.6 million in Q2 2025 from the same period last year, while for Jun 2025 it was $4.6 million, marking a year-over-year change of. This contributed to the annual value of $7.0 million for FY2024, which is 17.57% down from last year.
  • Ascentage Pharma Group International's Long-Term Deferred Tax amounted to $7.0 million in FY2024, which was down 17.57% from $8.5 million recorded in FY2023.
  • Over the past 5 years, Ascentage Pharma Group International's Long-Term Deferred Tax peaked at $934.6 million during FY2022, and registered a low of $7.0 million during FY2024.
  • In the last 3 years, Ascentage Pharma Group International's Long-Term Deferred Tax had a median value of $8.5 million in 2023 and averaged $316.7 million.
  • Data for Ascentage Pharma Group International's Long-Term Deferred Tax shows a maximum YoY plummeted of 99.09% (in 2023) over the last 5 years.
  • Ascentage Pharma Group International's Long-Term Deferred Tax (Yearly) stood at $934.6 million in 2022, then tumbled by 99.09% to $8.5 million in 2023, then dropped by 17.57% to $7.0 million in 2024.